AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SYNLOGIC, INC. Director's Dealing 2015

Oct 8, 2015

35028_dirs_2015-10-08_091807be-512d-4e2a-a1c4-61a1d6ce1af7.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Mirna Therapeutics, Inc. (MIRN)
CIK: 0001527599
Period of Report: 2015-10-05

Reporting Person: Cancer Prevention & Research Institute of Texas (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2395010	Direct